The DOI matches its Crossref record; 78 of the 79 references it cites were found in a registry or an index.
Effects of metformin and other biguanides on oxidative phosphorylation in mitochondria
Open accessAbstract
The biguanide metformin is widely prescribed for Type II diabetes and has anti-neoplastic activity in laboratory models. Despite evidence that inhibition of mitochondrial respiratory complex I by metformin is the primary cause of its cell-lineage-specific actions and therapeutic effects, the molecular interaction(s) between metformin and complex I remain uncharacterized. In the present paper, we describe the effects of five pharmacologically relevant biguanides on oxidative phosphorylation in mammalian mitochondria. We report that biguanides inhibit complex I by inhibiting ubiquinone reduction (but not competitively) and, independently, stimulate reactive oxygen species production by the complex I flavin. Biguanides also inhibit mitochondrial ATP synthase, and two of them inhibit only ATP hydrolysis, not synthesis. Thus we identify biguanides as a new class of complex I and ATP synthase inhibitor. By comparing biguanide effects on isolated complex I and cultured cells, we distinguish three anti-diabetic and potentially anti-neoplastic biguanides (metformin, buformin and phenformin) from two anti-malarial biguanides (cycloguanil and proguanil): the former are accumulated into mammalian mitochondria and affect oxidative phosphorylation, whereas the latter are excluded so act only on the parasite. Our mechanistic and pharmacokinetic insights are relevant to understanding and developing the role of biguanides in new and existing therapeutic applications, including cancer, diabetes and malaria.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source doesn’t support the claim as written.
In the citing paper
“inhibition of mitochondrial complex 1 in the electron transport chain and reduction of endogenous production of reactive oxygen species (ROS) (Batandier et al., 2006; Bridges et al., 2014; Zheng et al., 2012)”
From Metformin as a tool to target aging (2016) · cites this paper as Bridges et al., 2014
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“inhibition of mitochondrial complex 1 in the electron transport chain and reduction of endogenous production of reactive oxygen species (ROS) (Batandier et al., 2006; Bridges et al., 2014; Zheng et al., 2012)”
From Metformin as a tool to target aging (2016) · cites this paper as Bridges et al., 2014
In the citing paper
“However, metformin, one of the commonly prescribed drugs for treating type II diabetes, is safe despite acting as a mitochondrial complex I inhibitor that impairs respiration (Bridges et al., 2014; El-Mir et al., 2000; Owen et al., 2000; Wheaton et al., 2014).”
From Targeting Metabolism for Cancer Therapy (2017) · cites this paper as Bridges et al., 2014
In the citing paper
“It is also worthy of note that the IC50 for metformin to inhibit mitochondrial complex 1 is 19–66 mM (140, 141).”
From A Critical Review of the Evidence That Metformin Is a Putative Anti-Aging Drug That Enhances Healthspan and Extends Lifespan (2021) · cites this paper as [141]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Activation of the AMP-activated Protein Kinase by the Anti-diabetic Drug Metformin in Vivo
Zou, M., Kirkpatrick, S. S., Davis, B. J., Nelson, J. S., Wiles, W. G., Schlattner, U., Neumann, D., Brownlee, M., Freeman, M. B., & Goldman, M. H. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m404421200 · Cited by 480
RetractedUnderstanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation
Vander Heiden, M. G., Cantley, L. C., & Thompson, C. B. (2009) · Science · doi:10.1126/science.1160809 · Cited by 16,197
How mitochondria produce reactive oxygen species
Murphy, M. P. (2009) · Biochemical Journal · doi:10.1042/bj20081386 · Cited by 8,207
Watterson, K. R., Bestow, D., Gallagher, J. R., Hamilton, D. L., Ashford, F. B., Meakin, P. J., & Ashford, M. L. J. (2012) · Neurosignals · doi:10.1159/000334144 · Cited by 3,395
OWEN, M. R., DORAN, E., & HALESTRAP, A. P. (2000) · Biochemical Journal · doi:10.1042/bj3480607 · Cited by 2,157
The Kinase LKB1 Mediates Glucose Homeostasis in Liver and Therapeutic Effects of Metformin
Shaw, R. J., Lamia, K. A., Vasquez, D., Koo, S.-H., Bardeesy, N., DePinho, R. A., Montminy, M., & Cantley, L. C. (2005) · Science · doi:10.1126/science.1120781 · Cited by 1,950
Kinaan, M., Ding, H., & Triggle, C. R. (2015) · Medical Principles and Practice · doi:10.1159/000381643 · Cited by 1,515
El-Mir, M.-Y., Nogueira, V., Fontaine, E., Avéret, N., Rigoulet, M., & Leverve, X. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.1.223 · Cited by 1,399
Metformin—mode of action and clinical implications for diabetes and cancer
Pernicova, I., & Korbonits, M. (2014) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2013.256 · Cited by 1,393
Partial Resolution of the Enzymes Catalyzing Oxidative Phosphorylation
Kagawa, Y., & Racker, E. (1971) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)61930-1 · Cited by 1,361
Flagged first, then by citations
1 of the 79 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Items 201–300 of 661
Dietary nitrate supplementation in cardiovascular health: an ergogenic aid or exercise therapeutic?
Woessner, M. N., McIlvenna, L. C., Ortiz de Zevallos, J., Neil, C. J., & Allen, J. D. (2018) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00414.2017 · Cited by 50
Cork-in-bottle mechanism of inhibitor binding to mammalian complex I
Chung, I., Serreli, R., Cross, J. B., Francesco, M. E. D., Marszalek, J. R., & Hirst, J. (2021) · Science Advances · doi:10.1126/sciadv.abg4000 · Cited by 50
Self-citationThe Interplay between Immune System and Microbiota in Diabetes
Moffa, S., Mezza, T., CEFALO, C. M. A., Cinti, F., Impronta, F., Sorice, G. P., Santoro, A., Giuseppe, G. D., Pontecorvi, A., & Giaccari, A. (2019) · Mediators of Inflammation · doi:10.1155/2019/9367404 · Cited by 53
PYK2 promotes HER2-positive breast cancer invasion
Al-Juboori, S. I. K., Vadakekolathu, J. N., Idri, S., Wagner, S., Zafeiris, D., Pearson, J. R. D., Almshayakhchi, R., Caraglia, M., Desiderio, V., Miles, A. K., et al. (2019) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-019-1221-0 · Cited by 48
Metformin: review of epidemiology and mechanisms of action in pancreatic cancer
Eibl, G., & Rozengurt, E. (2021) · Cancer and Metastasis Reviews · doi:10.1007/s10555-021-09977-z · Cited by 51
Promising use of metformin in treating neurological disorders: biomarker-guided therapies
Loan, A., Syal, C., Lui, M., He, L., & Wang, J. (2023) · Neural Regeneration Research · doi:10.4103/1673-5374.385286 · Cited by 50
Sonnet, D. S., O’Leary, M. N., Gutierrez, M. A., Nguyen, S. M., Mateen, S., Hsu, Y.-M., Mitchell, K. P., Lopez, A. J., Vockley, J., Kennedy, B. K., et al. (2016) · Scientific Reports · doi:10.1038/srep28775 · Cited by 49
Regulation of organelle function by metformin
Kim, J., & You, Y. (2017) · IUBMB Life · doi:10.1002/iub.1633 · Cited by 50
Dysregulation of mRNA translation and energy metabolism in cancer
Leibovitch, M., & Topisirović, I. (2017) · Advances in Biological Regulation · doi:10.1016/j.jbior.2017.11.001 · Cited by 46
Veiga, S. R., Ge, X., Mercer, C. A., Hernández‐Álvarez, M. I., Thomas, H. E., Hernández‐Losa, J., y Cajal, S. R., Antonio Zorzano, A., Thomas, G., & Kozma, S. C. (2018) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-18-0177 · Cited by 49
Li, Q., Zhou, T. J., Wu, F., Li, N., Wang, R., Zhao, Q. S., Ma, Y., Zhang, J., & Ma, B. (2018) · Drug Metabolism Reviews · doi:10.1080/03602532.2018.1512614 · Cited by 49
Metabolic targeting of cancer by a ubiquinone uncompetitive inhibitor of mitochondrial complex I
Jain, S., Hu, C., Kluza, J., Ke, W., Tian, G., Giurgiu, M., Bleilevens, A., Campos, A. R., Charbono, A., Stickeler, E., et al. (2021) · Cell chemical biology · doi:10.1016/j.chembiol.2021.11.002 · Cited by 48
Linking Serine/Glycine Metabolism to Radiotherapy Resistance
Sánchez‐Castillo, A., Vooijs, M., & Kampen, K. R. (2021) · Cancers · doi:10.3390/cancers13061191 · Cited by 47
Heightening Energetic Stress Selectively Targets LKB1-Deficient Non–Small Cell Lung Cancers
Momcilovic, M., McMickle, R., Abt, E., Seki, A., Simko, S. A., Magyar, C., Stout, D. B., Fishbein, M. C., Walser, T. C., Dubinett, S. M., et al. (2015) · Cancer Research · doi:10.1158/0008-5472.can-15-0797 · Cited by 46
Overview of Metformin and Neurodegeneration: A Comprehensive Review
Kruczkowska, W., Gałęziewska, J., Buczek, P., Płuciennik, E., Kciuk, M., & Śliwińska, A. (2025) · Pharmaceuticals · doi:10.3390/ph18040486 · Cited by 52
Li, Y., Luo, J., Lin, M., Zhi, P., Guo, W.-W., Han, M. Y., You, J., & Gao, J. (2019) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.9b00199 · Cited by 45
Wokoun, U., Hellriegel, M., Emons, G., & Gründker, C. (2017) · Oncology Reports · doi:10.3892/or.2017.5491 · Cited by 45
Yasmin, T., Rahman, M. M., Khan, F., Kabir, F., Nahar, K., Lasker, S., Islam, M. D., Hossain, M. M., Hasan, R., Rana, S., et al. (2021) · Biochemistry and Biophysics Reports · doi:10.1016/j.bbrep.2021.101168 · Cited by 46
The new role of F1Fo ATP synthase in mitochondria-mediated neurodegeneration and neuroprotection
Mnatsakanyan, N., & Jonas, E. A. (2020) · Experimental Neurology · doi:10.1016/j.expneurol.2020.113400 · Cited by 44
Metabolic Pathways, Enzymes, and Metabolites: Opportunities in Cancer Therapy
Kumar, R., Mishra, A., Gautam, P., Feroz, Z., Vijayaraghavalu, S., Likos, E., Shukla, G. C., & Kumar, M. (2022) · Cancers · doi:10.3390/cancers14215268 · Cited by 50
Martins, L. F., Mesquita, J. T., Pinto, É. G., Costa‐Silva, T. A., Borborema, S. E. T., Galisteo, A. J., Neves, B. J., Andrade, C. H., Shuhaib, Z. A., Bennett, E. L., et al. (2016) · Journal of Natural Products · doi:10.1021/acs.jnatprod.6b00256 · Cited by 44
Mitochondria-targeted metformins: anti-tumour and redox signalling mechanisms
Kalyanaraman, B., Cheng, G., Hardy, M., Ouari, O., Sikora, A., Zielonka, J., & Dwinell, M. B. (2017) · Interface Focus · doi:10.1098/rsfs.2016.0109 · Cited by 44
Warkad, M. S., Kim, C.-H., Kang, B.-G., Park, S.-H., Jung, J., Feng, J., Inci, G., Kim, S.-C., Suh, H., Lim, S. S., et al. (2021) · Scientific Reports · doi:10.1038/s41598-021-93270-0 · Cited by 45
Barbieri, F., Bosio, A. G., Pattarozzi, A., Tonelli, M., Bajetto, A., Verduci, I., Cianci, F., Cannavale, G., Palloni, L. M. G., Francesconi, V., et al. (2022) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-021-02213-0 · Cited by 43
Jiaojiao, H., Wang, K., Zheng, N., Qiu, Y., Xie, G., Su, M., Jia, W. P., & Li, H. (2015) · Scientific Reports · doi:10.1038/srep17423 · Cited by 43
AG311, a small molecule inhibitor of complex I and hypoxia-induced HIF-1α stabilization
Bastian, A., Matsuzaki, S., Humphries, K. M., Pharaoh, G. A., Doshi, A., Zaware, N., Gangjee, A., & Ihnat, M. A. (2016) · Cancer Letters · doi:10.1016/j.canlet.2016.11.040 · Cited by 43
Schommers, P., Thurau, A., Bultmann-Mellin, I., Guschlbauer, M., Klatt, A. R., Rozman, J., Klingenspor, M., de Angelis, M. H., Alber, J., Gründemann, D., et al. (2017) · Molecular Metabolism · doi:10.1016/j.molmet.2017.05.002 · Cited by 42
Piccirillo, F., Carpenito, M., Verolino, G., Chello, C., Nusca, A., Lusini, M., Spadaccio, C., Nappi, F., Sciascio, G. D., & Nenna, A. (2019) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2019.111161 · Cited by 42
Shoshan‐Barmatz, V., Anand, U., Crystal, E. N., Carlo, M. D., & Shteinfer‐Kuzmine, A. (2021) · Frontiers in Physiology · doi:10.3389/fphys.2021.730048 · Cited by 42
Mitochondrial Metabolism in Melanoma
Huang, C. Y., Radi, R., & Arbiser, J. L. (2021) · Cells · doi:10.3390/cells10113197 · Cited by 40
Beerkens, A. P. M., Heskamp, S., Reinema, F. V., Adema, G. J., Span, P. N., & Bussink, J. (2025) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-24-3296 · Cited by 44
Yan, X., Zhang, G., Bie, F., Lv, Y., Ma, Y., Ma, M., Wang, Y., Hao, X., Yuan, N., & Jiang, X. (2017) · Scientific Reports · doi:10.1038/s41598-017-13505-x · Cited by 41
Metformin and cognition from the perspectives of sex, age, and disease
Chaudhari, K., Reynolds, C. D., & Yang, S.-H. (2020) · GeroScience · doi:10.1007/s11357-019-00146-3 · Cited by 43
Metabolomic Approaches to Investigate the Effect of Metformin: An Overview
Kim, H. W. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms221910275 · Cited by 44
Johnson, R. L., Cummings, M., Thangavelu, A., Theophilou, G., Jong, D. D., & Orsi, N. M. (2021) · Cancers · doi:10.3390/cancers13246231 · Cited by 39
Biphasic effect of metformin on human cardiac energetics
Emelyanova, L. V., Bai, X., Yan, Y., Bosnjak, Z. J., Kress, D. C., Warner, C., Kroboth, S., Rudic, T., Kaushik, S., Stoeckl, E. M., et al. (2020) · Translational research · doi:10.1016/j.trsl.2020.10.002 · Cited by 41
Metformin: Metabolic Rewiring Faces Tumor Heterogeneity
Cioce, M., Pulito, C., Strano, S., Blandino, G., & Fazio, V. M. (2020) · Cells · doi:10.3390/cells9112439 · Cited by 41
Meta-Assessment of Metformin Absorption and Disposition Pharmacokinetics in Nine Species
Jeong, Y., & Jusko, W. J. (2021) · Pharmaceuticals · doi:10.3390/ph14060545 · Cited by 43
AMPK modulation ameliorates dominant disease phenotypes of CTRP5 variant in retinal degeneration
Miyagishima, K. J., Sharma, R., Nimmagadda, M., Clore-Gronenborn, K., Qureshy, Z., Ortolan, D., Bose, D., Farnoodian, M., Zhang, C., Fausey, A., et al. (2021) · Communications Biology · doi:10.1038/s42003-021-02872-x · Cited by 43
Metformin inhibits cell proliferation in SKM-1 cells via AMPK-mediated cell cycle arrest
Zhou, X., Kuang, Y., Liang, S., & Wang, L. (2019) · Journal of Pharmacological Sciences · doi:10.1016/j.jphs.2019.10.003 · Cited by 39
Ungurianu, A., Șeremet, O. C., Gagniuc, E., Olaru, O. T., Guțu, C. M., Grădinaru, D., Ionescu-Tirgoviste, C., Margina, D. M., & Dănciulescu-Miulescu, R. (2019) · Pharmacological Research · doi:10.1016/j.phrs.2019.104522 · Cited by 39
Sung, J., & Cheong, J. (2022) · Cells · doi:10.3390/cells11050768 · Cited by 40
AMPK and Diseases: State of the Art Regulation by AMPK-Targeting Molecules
Tarasiuk, O., Miceli, M., Domizio, A. D., & Nicolini, G. (2022) · Biology · doi:10.3390/biology11071041 · Cited by 42
Off‐target effects of statins: molecular mechanisms, side effects and the emerging role of kinases
Lagunas‐Rangel, F. A., Liepinsh, E., Fredriksson, R., Alsehli, A. M., Williams, M. J., Dambrova, M., Jönsson, J., & Schiöth, H. B. (2024) · British Journal of Pharmacology · doi:10.1111/bph.17309 · Cited by 42
Targeting Mitochondrial Bioenergetics as a Therapeutic Strategy for Chronic Lymphocytic Leukemia
Chowdhury, S. R., & Banerji, V. (2018) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2018/2426712 · Cited by 39
Taming expectations of metformin as a treatment to extend healthspan
Konopka, A. R., & Miller, B. F. (2019) · GeroScience · doi:10.1007/s11357-019-00057-3 · Cited by 42
Abrosimov, R., Baeken, M. W., Hauf, S., Wittig, I., Hajieva, P., Perrone, C. E., & Moosmann, B. (2024) · GeroScience · doi:10.1007/s11357-023-01059-y · Cited by 37
Metformin reveals a mitochondrial copper addiction of mesenchymal cancer cells
Müller, S., Versini, A., Sindikubwabo, F., Belthier, G., Niyomchon, S., Pannequin, J., Grimaud, L., Cañeque, T., & Rodriguez, R. (2018) · PLoS ONE · doi:10.1371/journal.pone.0206764 · Cited by 35
Yakisich, J. S., Azad, N., Kaushik, V., & Iyer, A. K. V. (2019) · Stem Cells International · doi:10.1155/2019/6254269 · Cited by 36
Khaleghi-Mehr, M., Delshad, A.-A., Shafie-Damavandi, S., & Roghani, M. (2023) · Metabolic Brain Disease · doi:10.1007/s11011-023-01170-1 · Cited by 37
Yoshida, J., Ohishi, T., Abe, H., Ohba, S., Inoue, H., Usami, I., Amemiya, M., Oriez, R., Sakashita, C., Dan, S., et al. (2021) · iScience · doi:10.1016/j.isci.2021.103497 · Cited by 37
Isono, T., Chano, T., Yonese, J., & Yuasa, T. (2016) · Scientific Reports · doi:10.1038/srep25669 · Cited by 35
Teissier, T., Temkin, V., Pollak, R. D., & Cox, L. S. (2022) · Frontiers in Physiology · doi:10.3389/fphys.2022.812157 · Cited by 35
Bhaw‐Luximon, A., & Jhurry, D. (2016) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-016-2178-4 · Cited by 34
Cyclization-blocked proguanil as a strategy to improve the antimalarial activity of atovaquone
Skinner‐Adams, T. S., Fisher, G. M., Riches, A. G., Hutt, O. E., Jarvis, K. E., Wilson, T., von Itzstein, M., Chopra, P., Antonova‐Koch, Y., Meister, S., et al. (2019) · Communications Biology · doi:10.1038/s42003-019-0397-3 · Cited by 34
Mitochondrial targets of metformin—Are they physiologically relevant?
Pecinová, A., Brázdová, A., Drahota, Z., Houštěk, J., & Mráček, T. (2019) · BioFactors · doi:10.1002/biof.1548 · Cited by 33
Hypoxia and hyperglycaemia determine why some endometrial tumours fail to respond to metformin
Sivalingam, V. N., Latif, A., Kitson, S., McVey, R. J., Finegan, K. G., Marshall, K. M., Lisanti, M. P., Sotgia, F., Stratford, I. J., & Crosbie, E. J. (2019) · British Journal of Cancer · doi:10.1038/s41416-019-0627-y · Cited by 36
Moonira, T., Chachra, S. S., Ford, B. E., Marín, S., Alshawi, A., Adam-Primus, N. S., Arden, C., Al‐Oanzi, Z. H., Foretz, M., Viollet, B., et al. (2020) · Journal of Biological Chemistry · doi:10.1074/jbc.ra120.012533 · Cited by 35
Metformin Biodistribution: A Key to Mechanisms of Action?
Sundelin, E. I. O., Jensen, J., Jakobsen, S., Gormsen, L. C., & Jessen, N. (2020) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaa332 · Cited by 34
Ma, M., Ma, C., Li, P., Ma, C., Ping, F., Li, W., Xu, L., Zhang, H., Sun, Q., & Li, Y. (2020) · Cell Cycle · doi:10.1080/15384101.2020.1796036 · Cited by 34
Hohnholt, M. C., Blumrich, E., Waagepetersen, H. S., & Dringen, R. (2017) · Journal of Neuroscience Research · doi:10.1002/jnr.24050 · Cited by 34
Mitochondria and CancerPreprint
Kenny, T. C., & Birsoy, K. (2024) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a041534 · Cited by 40
Isop, L. M., Neculau, A. E., Necula, R. D., Kakucs, C., Moga, M., & Dima, L. (2023) · Pharmaceuticals · doi:10.3390/ph16121714 · Cited by 36
Zhang, C., Liu, T., Luo, P., Gao, L., Liao, X., Ma, L., Jiang, Z., Liu, D., Yang, Z., Jiang, Q., et al. (2021) · Science Advances · doi:10.1126/sciadv.abb6104 · Cited by 33
Huang, X., Huang, J., Du, J., Zhang, N., Long, Z., Yang, Y. Q., Zhong, F., Zheng, B., Shen, Y., Huang, Z., et al. (2021) · Acta Pharmacologica Sinica · doi:10.1038/s41401-021-00612-9 · Cited by 33
Metformin Is a Pyridoxal-5′-phosphate (PLP)-Competitive Inhibitor of SHMT2
Tramonti, A., Cuyàs, E., Encinar, J. A., Pietzke, M., Paone, A., Verdura, S., Arbusà, A., Martı́n-Castillo, B., Giardina, G., Joven, J., et al. (2021) · Cancers · doi:10.3390/cancers13164009 · Cited by 31
Xue, D., Xu, Y., Kyani, A., Roy, J., Dai, L., Sun, D., & Neamati, N. (2022) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.1c01934 · Cited by 33
Alternative Interventions to Prevent Oxidative Damage following Ischemia/Reperfusion
Rodríguez-Lara, S. Q., Cardona-Muñóz, E. G., Ramírez-Lizardo, E. J., Totsuka-Sutto, S. E., Castillo‐Romero, A., García-Cobián, T. A., & García‐Benavides, L. (2016) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2016/7190943 · Cited by 32
Repression of LKB1 by miR-17∼92 Sensitizes MYC-Dependent Lymphoma to Biguanide Treatment
Izreig, S., Gariepy, A., Kaymak, I., Bridges, H. R., Donayo, A. O., Bridon, G., DeCamp, L. M., Kitchen-Goosen, S. M., Avizonis, D. Z., Sheldon, R. D., et al. (2020) · Cell Reports Medicine · doi:10.1016/j.xcrm.2020.100014 · Cited by 31
Self-citationHeishima, K., Sugito, N., Soga, T., Nishikawa, M., Ito, Y., Honda, R. P., Kuranaga, Y., Sakai, H., Ito, R., Nakagawa, T., et al. (2021) · Journal of Clinical Investigation · doi:10.1172/jci139933 · Cited by 32
Amano, T., Chano, T., Isono, T., Kimura, F., Kushima, R., & Murakami, T. (2019) · World Journal of Surgical Oncology · doi:10.1186/s12957-019-1565-0 · Cited by 31
From old to new — Repurposing drugs to target mitochondrial energy metabolism in cancer
Aminzadeh-Gohari, S., Weber, D. D., Vidali, S., Catalano, L., Kofler, B., & Feichtinger, R. G. (2019) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2019.05.025 · Cited by 34
Biondo, L. A., Teixeira, A. A. S., Ferreira, K. C. D. O. S., & Neto, J. C. R. (2020) · Current Pharmaceutical Design · doi:10.2174/1381612826666200122124116 · Cited by 31
Papadakos, S. P., Ferraro, D., Carbone, G., Frampton, A. E., Vennarecci, G., Kykalos, S., Schizas, D., Theocharis, S. E., & Machairas, N. (2023) · Cancers · doi:10.3390/cancers15123161 · Cited by 31
Immuno-Metabolism: The Role of Cancer Niche in Immune Checkpoint Inhibitor Resistance
Weng, C.-Y., Kao, C.-X., Chang, T., & Huang, Y. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22031258 · Cited by 29
Targeting respiratory complex I to prevent the Warburg effect
Vatrinet, R., Iommarini, L., Kurelac, I., Luise, M. D., Gasparre, G., & Porcelli, A. M. (2015) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2015.01.017 · Cited by 31
Metformin and respiratory chain complex I: the last piece of the puzzle?
Fontaine, E. M. (2014) · Biochemical Journal · doi:10.1042/bj20141020 · Cited by 29
Dichloroacetate for Cancer Treatment: Some Facts and Many Doubts
Koltai, T., & Fliegel, L. (2024) · Pharmaceuticals · doi:10.3390/ph17060744 · Cited by 28
Repurposing bioenergetic modulators against protozoan parasites responsible for tropical diseases
Martínez-Flórez, A., Galizzi, M., Izquierdo, L., Bustamante, J. M., Rodrı́guez, A., Rodrı́guez, F., Rodríguez, A., & Alberola, J. (2020) · International Journal for Parasitology Drugs and Drug Resistance · doi:10.1016/j.ijpddr.2020.07.002 · Cited by 28
Exercise-Pharmacology Interactions: Metformin, Statins, and Healthspan
Miller, B. F., & Thyfault, J. P. (2020) · Physiology · doi:10.1152/physiol.00013.2020 · Cited by 30
AbuEid, M., McAllister, D. M., McOlash, L., Harwig, M. C., Cheng, G., Drouillard, D., Boyle, K. A., Hardy, M., Zielonka, J., Johnson, B. D., et al. (2021) · iScience · doi:10.1016/j.isci.2021.102653 · Cited by 28
Sung, J. Y., Kim, S. G., Kang, Y. J., & Choi, H. C. (2022) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2022.111708 · Cited by 29
Binding of Natural Inhibitors to Respiratory Complex I
Schiller, J., & Zickermann, V. (2022) · Pharmaceuticals · doi:10.3390/ph15091088 · Cited by 29
Galkin, A. S., & Moncada, S. (2017) · Interface Focus · doi:10.1098/rsfs.2016.0104 · Cited by 30
Pleiotropic Effects of Biguanides on Mitochondrial Reactive Oxygen Species Production
Pecinová, A., Drahota, Z., Kovalcikova, J., Kovářová, N., Pecina, P., Alán, L., Zima, M., Houštěk, J., & Mráček, T. (2017) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2017/7038603 · Cited by 27
Cruz‐Bermúdez, A., Vicente-Blanco, R. J., Briviesca, R. L., García‐Grande, A., Laine-Menéndez, S., Gutiérrez, L., Calvo, V., Romero, A., Martín, P., García, J. M., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-17009-6 · Cited by 28
Ahangarpour, A., Zeidooni, L., Rezaei, M., Alboghobeish, S., Samimi, A., & Oroojan, A. A. (2017) · Europe PMC (PubMed Central) · doi:10.22038/ijbms.2017.9567 · Cited by 27
Xue, D., Xu, Y., Kyani, A., Roy, J., Dai, L., Sun, D., & Neamati, N. (2022) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.1c01509 · Cited by 27
Udono, H., & Nishida, M. (2022) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2022.130171 · Cited by 27
Cummings, B. M., Needoba, J. A., & Peterson, T. D. (2018) · PLoS ONE · doi:10.1371/journal.pone.0207041 · Cited by 29
Coenzyme Q homeostasis in aging: Response to non-genetic interventions
López‐Lluch, G. (2021) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2021.01.024 · Cited by 29
Sloot, Y. J. E., Rabold, K., Netea, M. G., Smit, J. W. A., Hoogerbrugge, N., & Netea-Maier, R. T. (2019) · Oncogene · doi:10.1038/s41388-019-0685-x · Cited by 26
Conza, D., Mirra, P., Calı̀, G., Insabato, L., Fiory, F., Bèguinot, F., & Ulianich, L. (2021) · Cells · doi:10.3390/cells10051067 · Cited by 27
Kim, S., Im, J. H., Kim, W., Choi, Y. J., Lee, J. Y., Kim, S. K., Kim, S. J., Kwon, S. W., & Kang, K. W. (2021) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2021/5428364 · Cited by 26
The Hormetic Effect of Metformin: “Less Is More”?
Panfoli, I., Puddu, A., Bertola, N., Ravera, S., & Maggi, D. C. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22126297 · Cited by 29
Molecular and metabolic features of oncocytomas: Seeking the blueprints of indolent cancers
Luise, M. D., Girolimetti, G., Okere, B., Porcelli, A. M., Kurelac, I., & Gasparre, G. (2017) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/j.bbabio.2017.01.009 · Cited by 28
Metformin and Glaucoma—Review of Anti-Fibrotic Processes and Bioenergetics
Hurley, D. J., Irnaten, M., & O'Brien, C. J. (2021) · Cells · doi:10.3390/cells10082131 · Cited by 24
Pavlović, K., Jakovljevic, N. K., Isakovic, A. M., Ivanovic, T., Marković, I., & Lalic, N. M. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.930308 · Cited by 30
Imidacloprid affects rat liver mitochondrial bioenergetics by inhibiting FoF1-ATP synthase activity
Bizerra, P. F. V., Guimarães, A. R. D. J. S., Maioli, M. A., & Mingatto, F. E. (2018) · Journal of Toxicology and Environmental Health · doi:10.1080/15287394.2018.1437581 · Cited by 25
Gelin, L., Li, J., Corbin, K. L., Jahan, I., & Nunemaker, C. S. (2018) · Journal of Diabetes Research · doi:10.1155/2018/9163052 · Cited by 26
Metadata
- Authors
- Bridges, H. R., Jones, A. J. Y., Pollak, M. N., & Hirst, J.
- Affiliations
- MRC Mitochondrial Biology Unit (GB)
- Department of Oncology, McGill University and Lady Davis Research Institute of the Jewish General Hospital, Montreal, Quebec, Canada, H3T 1E2
- Corresponding author
- Hirst, Judy
- Venue
- Biochemical Journal
- Publisher
- Portland Press Ltd.
- Published
- 2014-08-22
- Volume
- 462
- Issue
- 3
- Pages
- 475-487
- ISSN
- 0264-6021 (ISSN-L)
- 1470-8728
- PMC
- PMC4148174
- OpenAlex
- W2012442095
- Cited by
- 661
- References
- 79
- Citations by year
- 2026: 30 · 2025: 53 · 2024: 45 · 2023: 41 · 2022: 61 · 2021: 95 · 2020: 72 · 2019: 66 · 2018: 64 · 2017: 60 · 2016: 43 · 2015: 22 · 2014: 9
- FWCI
- 18.33
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Locations
- Biochemical Journal (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Funders
- Canadian Institutes of Health Research
- Medical Research Council (U105663141)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Mitochondrial Function and Pathology
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › ATP Synthase and ATPases Research
- Keywords
- metformin, biguanides, oxidative phosphorylation, mitochondrial complex I, ubiquinone reduction, reactive oxygen species, ATP synthase inhibition, buformin, phenformin, cycloguanil, proguanil, mitochondrial accumulation, type 2 diabetes, anticancer activity, malaria
- MeSH terms
- Animals, Antimalarials, Antineoplastic Agents, Biguanides, Cattle, Proguanil, Diabetes Mellitus, Type 2, Humans, Metformin, Mitochondria, Heart, Mitochondria, Liver, Oxidative Phosphorylation, Plasmodium, Triazines, Reperfusion Injury, Mitochondrial Proton-Translocating ATPases, Electron Transport Complex I, Rats, Hep G2 Cells
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
